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Erythema nodosum migrans (ENM) is a rare
clinical variant of erythema nodosum (EN). It is a
septal panniculitis characterized by asymmetrical,
mildly tender, nodules that migrate over time.
Fever, sore throat, or arthralgias may also accom-
pany the cutaneous manifestations of the disease;
however, this is uncommon. The treatment of choice
for ENM is potassium iodide. We present a case of a
77-year-old woman with a 5- month history of ENM
that was treated successfully with topical clobetasol.CASE REPORT
A 77-year-old woman was referred to our derma-
tology clinic with a 5-month history of an enlarging,
erythematous to brownish indurated lesion on
the left thigh. The lesion was mildly tender and
expanding centrifugally over the last 5 months. No
physical trauma or infection preceded the lesion. Her
medical history included a hip replacement surgery,
cataracts, and hypothyroidism. She was taking
L-thyroxin for her hypothyroidism and her thyroid-
stimulating hormone levels were within the normal
range. Physical examination found a large annular
plaque on the medial left thigh with an erythematous
mildly tender border (Fig 1). No overlying ulceration
was observed. Based on the clinical presentation,
our differential diagnosis included eosinophilic
cellulitis, necrobiosis lipoidica, and morphea. A
punch biopsy was done to confirm the diagnosis;
however, results were inconclusive. At the second
clinical visit, the lesion appeared to have migrated
from the left medial thigh to the left lower limb
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clinical course (Figs 3 and 4). The histopathologic
findings were mild lymphohistiocytic infiltrate with
vascular proliferation in the superficial and deep
dermis. The subcutaneous tissue showed lympho-
histiocytic infiltrate and slight thickening. Some of
the lymphohistiocytic infiltrate extended to the
periphery of the subcutaneous lobules. No neutro-
philic infiltrate or well-formed granulomas were
seen. Overall, the changes were that of dermal and
subcutaneous septal lymphohistiocytic infiltrate with
vascular proliferation. The subcutaneous changes of
septal panniculitis observed were consistent with the
diagnosis of ENM.DISCUSSION
ENM was first described by Bafverstedt in 1954.1
Subsequently, Vilanova and Pinol Aguade2 referred
to the condition as subacute nodular migratory
panniculitis, and it has now come to be known as
Vilanova disease. The condition is characterized by
deep seated nodular lesions that often enlarge via
confluence or peripheral extension to form large
plaques.2 Classically, the lesions appear unilaterally
as single, discrete erythematous plaques. The
nodules do not ulcerate, and over weeks or months
the nodules may migrate and become crescentic in
nature.Toronto, ON M5S 1B2. E-mail: afsaneh.alavi@utoronto.ca,
afalavi@yahoo.com.
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Fig 1. Large subcutaneous plaque on the left medial thigh.
Fig 2. Large migratory plaque now observed on the left
shin.
Fig 4. Inflammatory infiltrates extending into the subcutis
with numerous histiocytes and lymphocytes in a septal
distribution.
Fig 3. Low-power image shows septal involvement of the
subcutaneous tissue. The dermis shows increased dense
vascularity.
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42 Mufti, Al-Mohammedi, and AlaviENM is more common in women, and it is often
compared with EN, which is the most common cause
of panniculitis. Lesions in ENM are less tender than
those in EN. The subcutaneous nodules or plaques in
ENM persist for a longer period compared with EN
nodules.3 Furthermore, ENM is typically unilateral,
whereas EN is typically bilateral. Most cases of ENM
are idiopathic in origin; however, a significant
proportion of EN cases are preceded by infection,
autoimmune disease, medication adverse effect, and
cancer. Although an underlying etiology is not
usually identified in ENM, streptococcal infection
has been implicated in some cases.3 Generally, EN is
self-limiting, whereas ENM lesions can last for
months.
Histologically, ENM may appear very similar
to EN. Classic EN shows septal panniculitis with
superficial and deep perivascular inflammatorylymphocytic infiltrate. As the disease progresses,
periseptal fibrosis, giant cells, and granulomatous
tissue appears.4,5 ENM, however, typically show
greater septal thickening and prominent granuloma-
tous inflammation along the subcutaneous septa.1
Vascular hyperplasia may also be present in some
cases.
Differential diagnosis for ENM includes EN,
pancreatic panniculitis, morphea, granuloma annu-
lare, necrobiosis lipoidica, and panniculitis caused
by foreign body and lupus panniculitis. Laboratory
studies helpful in diagnosis include erythrocyte
sedimentation rate (ESR), antistreptolysin O titer,
complete blood count, antinuclear antibody, and
a-1antitrypsin levels. The ESR is commonly elevated,
and antistreptolysin O is elevated in some patients.
CBC helps to rule out any infection, whereas
antinuclear antibody, a-1antitrypsin, serum amylase,
and serum lipase can help rule out other forms of
panniculitis. In our patient, the ESR was 25 mm/h,
within the normal range (2e30 mm/h), whereas the
neutrophil count was slightly elevated at 8.53 109/L
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results were within the normal range, ruling out any
form of panniculitis. The lack of clinical presentation
of necrobiosis lipoidica, including telangiectasia,
atrophy, and yellowish hue, along with the absence
of histopathologic changes of granuloma and
necrobiosis, exclude necrobiosis lipoidica from the
differential diagnosis.
Treatment options for ENM patients are generally
limited to potassium iodide and intralesional corti-
costeroids.6,7 Indomethacin and dapsone may also
be used to treat ENM; however, the evidence is very
limited.8,9 Untreated ENM can last from months to
years without treatment. In the case of our patient,
we prescribed topical clobetasol propionate cream
(0.05% twice daily for 2 weeks) to reduce the
inflammation, and her lesions have cleared up
completely. It is important to note that administration
of iodine-containing medications (eg, potassium
iodide, amiodarone) to patients being treated for
hypothyroidism, like our case, may lead to iodine
excess and subsequent Wolff-Chaikoff phenome-
non.10 In such patients, treating with topical clobe-
tasol may be a safer option.
This case shows the importance of considering
ENM in the differential diagnosis of suspected
morphea, necrobiosis lipoidica, and lower limb
cellulitis. Certain variants of the disease may present
with vascular changes in the dermis, as was seen inour case. This finding is quite atypical, and the
diagnosis is made primarily based on the characte-
ristic septal subcutaneous panniculitis. Although
ENM is a variant of EN, the correct diagnosis is
essential for appropriate management and patient
care.
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